SAN FRANCISCO (MarketWatch) -- Endo Pharmaceuticals Holdings Inc. said late Wednesday that Chief Executive Carol Ammon will step down from her position, but will remain chairwoman of its board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback